Biotest COVID-19 Antigen Rapid Test Cassette (Oral Fluid) obtains EU self-test certificate

Recently, the COVID-19 Antigen Rapid Test Cassette (Oral fluid) independently developed by Hangzhou Biotest Biotech Co., Ltd. has successfully obtained the EU CE self-test certificate.This is another breakthrough for Biotest after obtaining the EU CE self-test certificate for the COVID-19 Antigen Rapid Test Cassette（Nasal Swab）,The approval of this certification means that the COVID-19 Antigen Rapid Test Cassette (Oral Fluid&Nasal Swab) developed by Biotest can be marketed in the 27 EU member states and other countries that recognize the EU CE certification. Consumers can purchase in supermarkets, pharmacies and conduct simple and rapid self-testing.

Biotest COVID-19 Antigen Rapid Test Cassette has been registered in several countries and regions, including Germany, France, Italy, Switzerland, Czech, Brazil, Australia, Canada, Thailand, Hong Kong(CHN), etc. In addition, the COVID-19 Antigen Rapid Test Cassette produced by Biotest has also passed the evaluation and certification of Oxford University in the United Kingdom, and is also included in the EU general whitelist HSC Common List. According to the evaluation report of the German professional institution PEI, Biotest COVID-19 Antigen Rapid Test Cassette (Nasal Swab) ranks first in total sensitivity data among similar self-test products. Biotest COVID-19 Antigen Rapid Test Cassette has been unanimously recognized by distributors and users for its excellent performance and excellent quality. The CE self-test certification of the COVID-19 Antigen Rapid Test Cassette (Oral Fluid) further improves the company's COVID-19 testing product line, enhances the international competitiveness of the company's COVID-19 testing products, and lays a solid foundation for the steady development of the COVID-19 detection business in the era of normalized epidemic prevention and control.